Literature DB >> 22334863

Phage treatment of human infections.

Stephen T Abedon1, Sarah J Kuhl, Bob G Blasdel, Elizabeth Martin Kutter.   

Abstract

Phages as bactericidal agents have been employed for 90 years as a means of treating bacterial infections in humans as well as other species, a process known as phage therapy. In this review we explore both the early historical and more modern use of phages to treat human infections. We discuss in particular the little-reviewed French early work, along with the Polish, US, Georgian and Russian historical experiences. We also cover other, more modern examples of phage therapy of humans as differentiated in terms of disease. In addition, we provide discussions of phage safety, other aspects of phage therapy pharmacology, and the idea of phage use as probiotics.

Entities:  

Year:  2011        PMID: 22334863      PMCID: PMC3278644          DOI: 10.4161/bact.1.2.15845

Source DB:  PubMed          Journal:  Bacteriophage        ISSN: 2159-7073


  92 in total

Review 1.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  The phage therapy paradigm: prêt-à-porter or sur-mesure?

Authors:  Jean-Paul Pirnay; Daniel De Vos; Gilbert Verbeken; Maia Merabishvili; Nina Chanishvili; Mario Vaneechoutte; Martin Zizi; Geert Laire; Rob Lavigne; Isabelle Huys; Guy Van den Mooter; Angus Buckling; Laurent Debarbieux; Flavie Pouillot; Joana Azeredo; Elisabeth Kutter; Alain Dublanchet; Andrzej Górski; Revaz Adamia
Journal:  Pharm Res       Date:  2010-11-10       Impact factor: 4.200

3.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

Authors:  Lisa A Carmody; Jason J Gill; Elizabeth J Summer; Uma S Sajjan; Carlos F Gonzalez; Ryland F Young; John J LiPuma
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

4.  Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections.

Authors:  S Slopek; A Kucharewicz-Krukowska; B Weber-Dabrowska; M Dabrowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1985       Impact factor: 4.291

5.  Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases.

Authors:  S Slopek; A Kucharewicz-Krukowska; B Weber-Dabrowska; M Dabrowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1985       Impact factor: 4.291

6.  [Treatment of a case of endocarditis caused by Serratia with bacteriophages].

Authors:  P A Grimont; F Grimont; J Y Lacut; A M Issanchou; J Aubertin
Journal:  Nouv Presse Med       Date:  1978-06-24

7.  [Treatment of staphylococcal diseases of the eye].

Authors:  V A Proskurov
Journal:  Vestn Oftalmol       Date:  1970 Nov-Dec

8.  [Local immunity of the upper respiratory tract in patients with acute leukemia].

Authors:  V A Martynova; G L Ermakova; T V Golosova; E M Abakumov
Journal:  Vopr Onkol       Date:  1984

9.  In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.

Authors:  Marietta Weiss; Emmanuel Denou; Anne Bruttin; Ruth Serra-Moreno; Marie-Lise Dillmann; Harald Brüssow
Journal:  Virology       Date:  2009-08-21       Impact factor: 3.616

10.  Bacteriophage treatment of suppurative skin infections.

Authors:  M Cisło; M Dabrowski; B Weber-Dabrowska; A Woytoń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

View more
  284 in total

1.  Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

Authors:  Alex R Hall; Daniel De Vos; Ville-Petri Friman; Jean-Paul Pirnay; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  Molecular imaging of T4 phage in mammalian tissues and cells.

Authors:  Zuzanna Kaźmierczak; Agnieszka Piotrowicz; Barbara Owczarek; Katarzyna Hodyra; Paulina Miernikiewicz; Dorota Lecion; Marek Harhala; Andrzej Górski; Krystyna Dąbrowska
Journal:  Bacteriophage       Date:  2014-02-27

3.  Paenibacillus larvae-Directed Bacteriophage HB10c2 and Its Application in American Foulbrood-Affected Honey Bee Larvae.

Authors:  Hannes Beims; Johannes Wittmann; Boyke Bunk; Cathrin Spröer; Christine Rohde; Gabi Günther; Manfred Rohde; Werner von der Ohe; Michael Steinert
Journal:  Appl Environ Microbiol       Date:  2015-06-05       Impact factor: 4.792

Review 4.  Bacteriophage secondary infection.

Authors:  Stephen T Abedon
Journal:  Virol Sin       Date:  2015-01-13       Impact factor: 4.327

5.  Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections.

Authors:  Victor Krylov; Olga Shaburova; Elena Pleteneva; Sergey Krylov; Alla Kaplan; Maria Burkaltseva; Olga Polygach; Elena Chesnokova
Journal:  Virol Sin       Date:  2015-02-05       Impact factor: 4.327

Review 6.  Phage lytic enzymes: a history.

Authors:  David Trudil
Journal:  Virol Sin       Date:  2015-02-05       Impact factor: 4.327

Review 7.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

8.  Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk Patients.

Authors:  Austen L Terwilliger; Carmen Gu Liu; Sabrina I Green; Justin R Clark; Keiko C Salazar; Haroldo Hernandez Santos; Emmaline R Heckmann; Barbara W Trautner; Robert F Ramig; Anthony W Maresso
Journal:  Phage (New Rochelle)       Date:  2020-06-16

Review 9.  Ménage à trois in the human gut: interactions between host, bacteria and phages.

Authors:  Mohammadali Khan Mirzaei; Corinne F Maurice
Journal:  Nat Rev Microbiol       Date:  2017-05-02       Impact factor: 60.633

10.  Bacteriophage-based synthetic biology for the study of infectious diseases.

Authors:  Robert J Citorik; Mark Mimee; Timothy K Lu
Journal:  Curr Opin Microbiol       Date:  2014-07-03       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.